Sökning: onr:"swepub:oai:DiVA.org:kth-20593" >
Myocardial Doppler ...
Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A(165) plasmid in patients with inoperable angina pectoris
-
- Sylven, C. (författare)
- Karolinska Institutet
-
- Sarkar, N. (författare)
- Karolinska Institutet
-
- Ruck, A. (författare)
- Karolinska Institutet
-
visa fler...
-
Drvota, V. (författare)
-
- Y-Hassan, S. (författare)
- Karolinska Institutet
-
- Lind, B. (författare)
- Karolinska Institutet
-
- Nygren, A. (författare)
- Karolinska Institutet
-
- Kallner, G. (författare)
- Karolinska Institutet
-
Blomberg, P. (författare)
-
- van der Linden, J. (författare)
- Karolinska Institutet
-
- Lindblom, D. (författare)
- Karolinska Institutet
-
Brodin, Lars-Åke (författare)
-
Islam, K. B. (författare)
-
visa färre...
-
(creator_code:org_t)
- Ovid Technologies (Wolters Kluwer Health), 2001
- 2001
- Engelska.
-
Ingår i: Coronary Artery Disease. - : Ovid Technologies (Wolters Kluwer Health). - 0954-6928 .- 1473-5830. ; 12:3, s. 239-243
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background Myocardial tissue velocity and perfusion were studied in patients with severe angina pectoris following gene therapy by intramyocardial injection of phVEGF-A(165) via thoracotomy. Plasma concentrations of VEGF-A increased postoperatively. Two months after treatment anginal status and myocardial tissue velocity improved and perfusion showed a tendency to improve. Tissue velocity imaging appears to be a sensitive, objective method for detecting changes in myocardial function following gene therapy. Objective To study effects on myocardial tissue velocity and perfusion in patients with angina pectoris following intramyocardial injection of phVEGF-A(165) via thoracotomy. Design Open label, phase I/II. Methods Six patients with Canadian Cardiovascular Society (CCS) angina pectoris functional Glass III - IV and with major defects at adenosine stress single-photon emission computerized tomography (SPECT) were studied. In addition to SPECT, coronary angiography and dobutamine stress echocardiography with tissue Doppler velocity imaging were performed before and two months after gene transfer. Results Plasma concentrations of VEGF-A increased 2 to 3 times (P < 0.04) over baseline from 2 to 14 days after injection with normalization after 4 weeks. The CCS class improved about 40%, from 3.3 +/- 0.2 to 2.0 +/- 0.3 (P < 0.02) and nitroglycerine consumption decreased 30 - 40%, from 44 +/- 17 to 15 +/- 5 tablets per week (P < 0.05). The maximal systolic myocardial tissue velocity increased in all patients about 25% (P < 0.02) but did not reach the reference range. Myocardial perfusion at SPECT improved in four of the six patients. Conclusions Anginal status, myocardial tissue velocity and perfusion can be improved by phVEGF-A(165) intramyocardial injection. Tissue velocity imaging appears to be a sensitive, objective method for detecting changes in myocardial function following gene therapy. Coron Artery Dis 12:239-243
Nyckelord
- plasmid
- VEGF
- human
- coronary artery disease
- thoracotomy
- Doppler
- perfusion
- echocardiography
- disease
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Sylven, C.
-
Sarkar, N.
-
Ruck, A.
-
Drvota, V.
-
Y-Hassan, S.
-
Lind, B.
-
visa fler...
-
Nygren, A.
-
Kallner, G.
-
Blomberg, P.
-
van der Linden, ...
-
Lindblom, D.
-
Brodin, Lars-Åke
-
Islam, K. B.
-
visa färre...
- Artiklar i publikationen
-
Coronary Artery ...
- Av lärosätet
-
Kungliga Tekniska Högskolan
-
Karolinska Institutet